Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#101 / 200 Total
INDI - Indie Semiconductor Inc - Stock Price Chart
TickerINDI [NASD, RUT]
CompanyIndie Semiconductor Inc
CountryUSA
IndustrySemiconductor Equipment & Materials
Market Cap1.05BEPS (ttm)-0.49
P/E-EPS this Y20.07%
Forward P/E35.34EPS next Y176.19%
PEG-EPS past 5Y-
P/S4.46EPS next 5Y-
P/B2.31EPS Q/Q65.76%
Dividend-Sales Q/Q29.42%
Insider Own16.35%Inst Own71.30%
Insider Trans-1.55%Inst Trans15.27%
Short Float17.30%EarningsMay 09/a
Analyst Recom1.12Target Price11.10
Avg Volume2.93M52W Range4.67 - 10.85
Today 12:46PM indie Semiconductor, Inc. (NASDAQ:INDI) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-09-24 04:30PM indie Semiconductor Reports First Quarter 2024 Results (Business Wire)
May-01-24 04:30PM 7 Penny Stocks That Could Make You a Fortune (If You Dare) (InvestorPlace)
Apr-22-24 09:00AM indie Semiconductor Launches Advanced Smart Connectivity Solutions for In-Cabin Applications (Business Wire)
Apr-11-24 09:00AM indie Semiconductor Sets Date for First Quarter 2024 Earnings Release and Conference Call (Business Wire)
Mar-25-24 11:45AM Jim Cramer Says You Should Avoid These 11 Stocks (Insider Monkey)
Mar-20-24 04:05PM indie Semiconductor Announces Strategic Investment in AI Processor Leader Expedera (Business Wire)
Mar-08-24 04:30PM indie Semiconductor Announces New Employee Inducement Grants (Business Wire)
Feb-27-24 09:00AM indie Semiconductor to Participate at Upcoming Investor Events (Business Wire)
DTCK - Davis Commodities Ltd. - Stock Price Chart
TickerDTCK [NASD]
CompanyDavis Commodities Ltd.
CountrySingapore
IndustryFarm Products
Market Cap26.69MEPS (ttm)0.16
P/E6.63EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.18EPS next 5Y-
P/B4.30EPS Q/Q78.41%
Dividend-Sales Q/Q-0.82%
Insider Own98.73%Inst Own0.32%
Insider Trans0.00%Inst Trans-
Short Float14.38%Earnings-
Analyst Recom-Target Price-
Avg Volume280.89K52W Range0.76 - 9.00
Jan-29-24 08:00AM Davis Commodities Limited Releases 2024 Chairwoman Letter to Shareholders (GlobeNewswire) -5.27%
Dec-29-23 08:00AM Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results (GlobeNewswire) +8.33%
Sep-21-23 04:20PM Univest Securities, LLC Announces Closing of $5 Million Initial Public Offering of Ordinary Shares and Full Exercise of Exercise of Underwriters Over-Allotment Option for its Client Davis Commodities Limited (Nasdaq: DTCK) (GlobeNewswire)
04:05PM Davis Commodities Limited Announces Closing of Initial Public Offering Including Full Exercise of Over-Allotment Option (GlobeNewswire)
Sep-18-23 07:00PM Davis Commodities Limited Announces Pricing of Initial Public Offering (GlobeNewswire)
AMPX - Amprius Technologies Inc - Stock Price Chart
TickerAMPX [NYSE, RUT]
CompanyAmprius Technologies Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap187.27MEPS (ttm)-0.43
P/E-EPS this Y1.66%
Forward P/E-EPS next Y12.89%
PEG-EPS past 5Y-
P/S20.69EPS next 5Y-
P/B2.95EPS Q/Q-53.63%
Dividend-Sales Q/Q397.98%
Insider Own83.47%Inst Own4.73%
Insider Trans-2.11%Inst Trans-
Short Float11.75%EarningsMay 09/a
Analyst Recom1.29Target Price10.33
Avg Volume619.25K52W Range1.56 - 10.63
May-09-24 05:30PM Amprius Technologies (AMPX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM Amprius Technologies Reports First Quarter 2024 Business and Financial Results (Business Wire)
08:30AM Amprius to Integrate Safe Cells into Next-Generation U.S. Army Wearable Battery Pack (Business Wire)
May-07-24 10:00AM Gateway Group Announces Preliminary Presenting Companies for Gateway Conference in San Francisco on September 4-5, 2024 (GlobeNewswire) -11.16%
May-02-24 10:00AM Amprius Technologies (AMPX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks) +7.46%
May-01-24 08:30AM Amprius Sets May 2024 Events Schedule (Business Wire) +7.49%
Apr-30-24 09:00AM Global Silicon-Based Anode Battery Market Size Is Expected to Reach $3.4 Billion By End of 2031 (PR Newswire)
08:30AM KULR Technology Group and Amprius Technologies Form Strategic Partnership for Advanced Battery Packs (GlobeNewswire)
08:30AM Amprius Hosts Battery Forum in Taiwan and Presents on its Strategy to Power the Future of Electric Mobility (Business Wire)
Apr-25-24 08:30AM Amprius Technologies Announces Date for First Quarter 2024 Results and Business Updates (Business Wire)
FHTX - Foghorn Therapeutics Inc - Stock Price Chart
TickerFHTX [NASD, RUT]
CompanyFoghorn Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap221.47MEPS (ttm)-2.21
P/E-EPS this Y9.74%
Forward P/E-EPS next Y22.25%
PEG-EPS past 5Y-26.80%
P/S6.53EPS next 5Y-
P/B-EPS Q/Q19.14%
Dividend-Sales Q/Q-4.88%
Insider Own56.05%Inst Own30.86%
Insider Trans-0.05%Inst Trans-0.31%
Short Float7.03%EarningsMay 06/b
Analyst Recom1.00Target Price16.33
Avg Volume106.09K52W Range2.70 - 9.97
May-09-24 07:00AM Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management (PR Newswire)
May-06-24 02:52PM FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:32AM Foghorn Therapeutics Q1 2024 Earnings: Misses Analyst Revenue Projections Amidst Strategic ... (GuruFocus.com)
08:10AM Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update (GlobeNewswire)
Apr-16-24 07:00AM Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer (GlobeNewswire) -5.63%
Apr-09-24 04:30PM Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs (GlobeNewswire)
Apr-08-24 08:00AM Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences (PR Newswire)
Apr-05-24 07:00AM Foghorn Therapeutics to Participate in Needham's 23rd Annual Virtual Healthcare Conference (GlobeNewswire)
Apr-02-24 09:55AM Does Foghorn Therapeutics (FHTX) Have the Potential to Rally 105.75% as Wall Street Analysts Expect? (Zacks)
NNVC - NanoViricides Inc - Stock Price Chart
TickerNNVC [AMEX]
CompanyNanoViricides Inc
CountryUSA
IndustryBiotechnology
Market Cap20.97MEPS (ttm)-0.80
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.25%
P/S-EPS next 5Y-
P/B1.68EPS Q/Q-19.83%
Dividend-Sales Q/Q-
Insider Own4.62%Inst Own10.17%
Insider Trans0.00%Inst Trans19.17%
Short Float0.89%EarningsFeb 16/a
Analyst Recom1.00Target Price6.50
Avg Volume73.54K52W Range1.00 - 2.13
Today 06:30AM NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City (ACCESSWIRE)
May-08-24 06:30AM A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox (ACCESSWIRE) +20.83%
May-06-24 06:30AM A Novel Broad-Spectrum Antiviral with Activity Against Influenza A (ACCESSWIRE) +23.89%
May-02-24 06:30AM 3 Nanotech Stocks With the Potential to Make You an Overnight Millionaire (InvestorPlace) +6.19%
Apr-30-24 06:30AM NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon (ACCESSWIRE) +6.19%
Feb-15-24 06:30AM NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon (ACCESSWIRE)
Feb-14-24 05:11PM NanoViricides: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Feb-01-24 06:20AM Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics (ACCESSWIRE)
Jan-29-24 06:30AM Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found (ACCESSWIRE) +9.35%
Jan-04-24 06:30AM NanoViricides to Present at the Biotech Showcase in San Fransisco (ACCESSWIRE) +5.83%
ACET - Adicet Bio Inc - Stock Price Chart
TickerACET [NASD, RUT]
CompanyAdicet Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap121.22MEPS (ttm)-3.32
P/E-EPS this Y43.84%
Forward P/E-EPS next Y-0.99%
PEG-EPS past 5Y19.75%
P/S-EPS next 5Y29.10%
P/B0.38EPS Q/Q4.48%
Dividend-Sales Q/Q-
Insider Own18.24%Inst Own40.78%
Insider Trans71.53%Inst Trans7.12%
Short Float11.42%EarningsMar 19/a
Analyst Recom1.50Target Price9.20
Avg Volume1.43M52W Range1.10 - 7.50
May-07-24 07:00AM Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference (Business Wire)
Apr-30-24 05:10PM Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.29%
Apr-22-24 04:30PM Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting (Business Wire)
Apr-08-24 07:00AM Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Apr-04-24 08:38AM Why Adicet Bio (ACET) Stock Might be a Great Pick (Zacks)
Apr-01-24 09:40AM Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-28-24 05:19PM Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-22-24 09:35AM Adicet Bio (ACET) Loses -16.39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +7.35%
Mar-19-24 09:53PM ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023 (InvestorPlace)
04:10PM Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress (Business Wire)
PODD - Insulet Corporation - Stock Price Chart
TickerPODD [NASD, S&P 500]
CompanyInsulet Corporation
CountryUSA
IndustryMedical Devices
Market Cap11.63BEPS (ttm)3.30
P/E50.29EPS this Y3.90%
Forward P/E44.12EPS next Y23.25%
PEG2.78EPS past 5Y122.47%
P/S6.53EPS next 5Y18.10%
P/B15.85EPS Q/Q115.02%
Dividend-Sales Q/Q23.35%
Insider Own0.64%Inst Own102.70%
Insider Trans-9.43%Inst Trans-0.61%
Short Float4.23%EarningsMay 09/a
Analyst Recom1.42Target Price233.82
Avg Volume880.39K52W Range125.82 - 331.65
Today 12:24PM Insulet Corp (PODD) Reports Strong Q1 2024 Results and Raises Full-Year Guidance (GuruFocus.com) -6.43%
09:43AM Analyst Report: Insulet Corporation (Morningstar Research)
09:24AM Raymond James Adjusts Price Target on Insulet to $213 From $218 (MT Newswires)
08:10AM Wolfe Research Raises Price Target on Insulet to $205 From $200 (MT Newswires)
08:00AM Canaccord Genuity Adjusts Price Target on Insulet to $234 From $226 (MT Newswires)
07:49AM Jefferies Raises Price Target on Insulet to $260 From $255 (MT Newswires)
May-09-24 08:57PM PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:30PM Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings (Zacks)
04:30PM Insulet Q1 Earnings, Revenue Rise; 2024 Revenue Growth Boosted (MT Newswires)
04:11PM Insulet: Q1 Earnings Snapshot (Associated Press Finance)
AUGX - Augmedix Inc - Stock Price Chart
TickerAUGX [NASD]
CompanyAugmedix Inc
CountryUSA
IndustryHealth Information Services
Market Cap112.39MEPS (ttm)-0.44
P/E-EPS this Y-13.64%
Forward P/E-EPS next Y32.50%
PEG-EPS past 5Y62.58%
P/S2.51EPS next 5Y-
P/B4.78EPS Q/Q38.77%
Dividend-Sales Q/Q44.90%
Insider Own10.23%Inst Own74.65%
Insider Trans27.11%Inst Trans0.68%
Short Float3.84%EarningsMay 13/a
Analyst Recom1.00Target Price6.10
Avg Volume372.93K52W Range2.46 - 6.25
May-03-24 07:00AM Augmedix to Participate in Upcoming Investor Conferences in May and June 2024 (GlobeNewswire)
Apr-30-24 07:00AM Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
Apr-25-24 04:05PM Augmedix Awarded on Newsweek's World's Best Digital Health Companies 2024 List (GlobeNewswire)
Apr-24-24 07:00AM Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments (GlobeNewswire)
Apr-19-24 06:00AM 3 Penny Stocks That Could Make a Big Comeback by the End of Q2 (InvestorPlace)
Apr-12-24 02:05AM Insider Sell: Augmedix Inc's (AUGX) Chief Strategy Officer Ian Shakil Sells 92,787 Shares (GuruFocus.com)
Apr-10-24 01:51AM Augmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 89,167 Shares (GuruFocus.com) -5.17%
Apr-09-24 07:00AM Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care (GlobeNewswire)
Apr-05-24 02:42AM Augmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 109,961 Shares (GuruFocus.com)
Apr-04-24 07:00AM Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide (GlobeNewswire)
BCAB - BioAtla Inc - Stock Price Chart
TickerBCAB [NASD, RUT]
CompanyBioAtla Inc
CountryUSA
IndustryBiotechnology
Market Cap128.93MEPS (ttm)-2.58
P/E-EPS this Y25.09%
Forward P/E-EPS next Y8.17%
PEG-EPS past 5Y-25.30%
P/S-EPS next 5Y-
P/B1.82EPS Q/Q10.43%
Dividend-Sales Q/Q-
Insider Own19.39%Inst Own55.14%
Insider Trans0.92%Inst Trans11.55%
Short Float13.74%EarningsMay 14/a
Analyst Recom1.00Target Price11.50
Avg Volume608.40K52W Range1.24 - 4.07
May-08-24 08:00AM BioAtla to Participate in the Citizens JMP Life Sciences Conference (GlobeNewswire)
May-07-24 08:00AM BioAtla to Announce First Quarter 2024 Financial Results and Provide Business Highlights on May 14, 2024 (GlobeNewswire)
May-06-24 09:14AM BioAtla's Multiple Cancer Drug Candidate Receives FDA Clearance (MT Newswires)
08:00AM BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors (GlobeNewswire)
Apr-24-24 04:35PM BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Mar-27-24 10:07AM BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript (Insider Monkey) +14.95%
07:56AM Q4 2023 Bioatla Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 09:54PM BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023 (InvestorPlace) +29.18%
05:33PM BioAtla Inc (BCAB) Posts Q4 and Full Year 2023 Financial Results (GuruFocus.com)
04:01PM BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress (GlobeNewswire)
OCEA - Ocean Biomedical Inc. - Stock Price Chart
TickerOCEA [NASD, RUT]
CompanyOcean Biomedical Inc.
CountryUSA
IndustryBiotechnology
Market Cap54.05MEPS (ttm)-3.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-587.66%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own13.49%
Insider Trans0.00%Inst Trans2.64%
Short Float8.01%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume6.98M52W Range0.52 - 12.08
Apr-24-24 04:51PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K (GlobeNewswire)
Mar-28-24 01:15PM 13 Hot Stocks to Invest in According to Wall Street Analysts (Insider Monkey) -6.77%
08:01AM Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL (GlobeNewswire)
Mar-24-24 03:52PM 5 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-05-24 08:30AM Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments (GlobeNewswire) +28.92%
Feb-29-24 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting (GlobeNewswire) +14.29%
Dec-05-23 09:45AM EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody (Benzinga)
08:15AM Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody (GlobeNewswire)
Nov-29-23 05:41PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) -8.95%
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
1⋯678910111213141516⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.